Study of serum beta-2 microglobulin levels in breast cancer patients.
Serum beta-2 microglobulin levels were measured in normal individuals and in breast cancer patients. It was observed that there was a significant rise in levels especially in advanced stages of the disease. It was concluded that patients with a beta-2 microglobulin/creatinine ratio of greater than 3.8 were likely to have metastatic breast cancer.
D001609:Beta-Globulins / Q000032:analysis*; D001943:Breast Neoplasms / Q000097:blood*; D003404:Creatinine / Q000097:blood; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D012016:Reference Values; D001613:beta 2-Microglobulin / Q000032:analysis*
D001609:Beta-Globulins; D001613:beta 2-Microglobulin; D003404:Creatinine